Cancer

iCAD Added to Russell Microcap Index

Published in Lab Business Week, August 12th, 2007

iCAD, Inc. (NASDAQ:ICAD) an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, announced it has been added to the Russell Microcap(R) Index when the Russell Investment Group reconstituted its comprehensive set of U.S. and global equity indexes on June 22.

iCAD, Inc. offers a range of CAD products to enhance the early identification of cancer. SecondLook(R), approved by the FDA in 2002, provides a computerized second review of both screening and diagnostic mammograms. TotalLook(R), introduced by iCAD at the end of 2005, provides customers with a comprehensive film-to-digital solution making it easier for women's...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2007-08-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry